Comment on 'Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ?50% treated with front-line pembrolizumab' için istatistikler

Toplam ziyaret

views
Comment on 'Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ?50% treated with front-line pembrolizumab' 0

Aylık toplam ziyaret

views
Ekim 2024 0
Kasım 2024 0
Aralık 2024 0
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0